Immuron Limited
IMRN · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 48.6% | 171.7% | 135.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 65.4% | 68.1% | 96.4% | 68.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -72.8% | -105.4% | -186.2% | -403.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -71.6% | -141.5% | -209.8% | -373% |
| EPS Diluted | -0.9 | -1.22 | -0.66 | -0.5 |
| % Growth | 26.2% | -84.8% | -32% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |